John Poyhonen, EVP, Chief Commercial Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 10,286 shares at $17.50 ($180K) on 2019-10-03, disclosed to the SEC on 2019-10-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.50 | 5,143 | $90K | 50.0% |
| 2 | $17.50 | 5,143 | $90K | 50.0% |
| Total | $17.50 avg | 10,286 | $180K | 100% |
| Filing → |
| HRTX | BUY | 2017-01-23 | $122K | — | Filing → |
| SNMX | SELL | 2014-06-06 | $301K | — | Filing → |
| RDEA | SELL | 2011-06-03 | $136K | — | Filing → |